分子癌癥治療學(xué)將側(cè)重于在以下領(lǐng)域?qū)Π┌Y治療具有意義的基礎(chǔ)研究:實(shí)驗(yàn)癌癥治療學(xué)、分子靶點(diǎn)的識(shí)別、化學(xué)預(yù)防靶點(diǎn)、新模型、癌癥化學(xué)和藥物發(fā)現(xiàn)、分子和細(xì)胞藥理學(xué)、腫瘤分子分類、生物信息學(xué)和計(jì)算分子生物學(xué)。該雜志為這些新興學(xué)科提供了一個(gè)專門關(guān)注癌癥研究的出版論壇。論文經(jīng)過嚴(yán)格審查，只有那些報(bào)告新穎、及時(shí)、有意義的研究結(jié)果并符合高科學(xué)價(jià)值標(biāo)準(zhǔn)的論文才會(huì)被接受發(fā)表。

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.